Ligand Pharmaceuticals, Inc. (LGND) Misses Q2 EPS by 18c

August 8, 2012 4:38 PM

Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) reported Q2 EPS of ($0.20) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found